Publikationer i DiVA – Magnus Essand
-
CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
Ingår i Nature Biomedical Engineering, s. 830-841, 2022.
DOI för CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers Ladda ner fulltext (pdf) av CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
-
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation
Ingår i Molecular Therapy - Nucleic Acids, s. 450-461, 2022.
DOI för CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation Ladda ner fulltext (pdf) av CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN1 M146L mutation
-
Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
Ingår i Oncoimmunology, 2022.
DOI för Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response Ladda ner fulltext (pdf) av Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-turnor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
-
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Ingår i Cancer Gene Therapy, s. 1628-1635, 2022.
DOI för Ixovex-1, a novel oncolytic E1B-mutated adenovirus Ladda ner fulltext (pdf) av Ixovex-1, a novel oncolytic E1B-mutated adenovirus
-
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
Ingår i Cancer Imaging, 2022.
DOI för Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy Ladda ner fulltext (pdf) av Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
-
ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
Ingår i Frontiers in Immunology, 2022.
DOI för ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression Ladda ner fulltext (pdf) av ZC3H11A loss of function enhances NF-κB signaling through defective IκBα protein expression
-
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
Ingår i Nature Communications, 2021.
DOI för Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma Ladda ner fulltext (pdf) av Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
-
Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy
Ingår i Nanomaterials, 2021.
DOI för Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy Ladda ner fulltext (pdf) av Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy
-
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
Ingår i MOLECULAR THERAPY-ONCOLYTICS, s. 37-46, 2021.
DOI för IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma Ladda ner fulltext (pdf) av IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
-
Perivascular macrophages regulate blood flow following tissue damage
Ingår i Circulation Research, s. 1694-1707, 2021.
DOI för Perivascular macrophages regulate blood flow following tissue damage
-
Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
Ingår i Frontiers in Immunology, 2021.
DOI för Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma Ladda ner fulltext (pdf) av Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
-
Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain
Ingår i Journal of Neuroinflammation, 2020.
DOI för Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain Ladda ner fulltext (pdf) av Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain
-
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
Ingår i Cell Death and Disease, 2020.
DOI för Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer Ladda ner fulltext (pdf) av Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
-
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
Ingår i Haematologica, s. 1306-1316, 2020.
DOI för TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment Ladda ner fulltext (pdf) av TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
-
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Ingår i Oncoimmunology, 2020.
DOI för Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy Ladda ner fulltext (pdf) av Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
-
Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy
Ingår i Cell Stem Cell, s. 855-870, 2019.
DOI för Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy Ladda ner fulltext (pdf) av Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy
-
LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients
Ingår i Journal of Pathology, s. 228-240, 2019.
-
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
Ingår i Clinical Cancer Research, s. 6185-6194, 2018.
-
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
Ingår i Oncoimmunology, 2018.
DOI för Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models Ladda ner fulltext (pdf) av Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
-
CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
Ingår i Journal of Clinical Investigation, s. 3280-3297, 2018.
DOI för CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis Ladda ner fulltext (pdf) av CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
-
Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity
Ingår i Molecular Cancer Therapeutics, s. 1961-1972, 2018.
DOI för Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity Ladda ner fulltext (pdf) av Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity
-
Modifying melanoma immune microenvironment by heterologous prime-boost vaccination with adenovirus and Modified Vaccinia Ankara virus vectors
Ingår i Experimental dermatology, s. E54-E55, 2018.
-
Multiple nuclear-replicating viruses require the stress-induced protein ZC3H11A for efficient growth
Ingår i Proceedings of the National Academy of Sciences of the United States of America, s. E3808-E3816, 2018.
-
Perivascular macrophages regulate blood flow following tissue damage
Ingår i European Journal of Clinical Investigation, s. 44-45, 2018.
DOI för Perivascular macrophages regulate blood flow following tissue damage
-
Adenovirus, Semliki Forest virus and vaccinia virus-induced immunogenic cell death augments oncolytic virus immunotherapy
Ingår i Scandinavian Journal of Immunology, s. 341-341, 2017.
-
CAR T-Cells with Induced Secretion of Helicobacter Pylori Neutrophil-Activating Protein (HP-NAP) Yields Improved Anti-Tumor Activity and Reduced Immunosuppression
Ingår i Molecular Therapy, s. 288-288, 2017.
-
Immunological biomarkers correlate to survival in CAR19-treated patients
Ingår i Scandinavian Journal of Immunology, s. 337-337, 2017.
-
PATZ1 down-regulates FADS1 by binding to rs174557 and is opposed by SP1/SREBP1c
Ingår i Nucleic Acids Research, s. 2408-2422, 2017.
DOI för PATZ1 down-regulates FADS1 by binding to rs174557 and is opposed by SP1/SREBP1c
-
Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer
Ingår i Neuroendocrinology, s. 54-66, 2017.
-
Safe and effective treatment of experimental neuroblastoma and glioblastoma using systemically administered triple microRNA-detargeted oncolytic Semliki Forest virus
Ingår i Clinical Cancer Research, s. 1519-1530, 2017.
-
The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells
Ingår i Seminars in Cancer Biology, s. 23-35, 2017.
DOI för The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells Ladda ner fulltext (pdf) av The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells
-
A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia
Ingår i Molecular Therapy, s. S295-S296, 2016.
-
Avidity characterization of genetically engineered T-cells with novel and established approaches
Ingår i BMC Immunology, 2016.
DOI för Avidity characterization of genetically engineered T-cells with novel and established approaches Ladda ner fulltext (pdf) av Avidity characterization of genetically engineered T-cells with novel and established approaches
-
CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia: report from the Swedish phase Ulla trial
Ingår i CANCER IMMUNOLOGY RESEARCH, 2016.
-
Heparanase Promotes Glioma Progression and is Inversely Correlated with Patient Survival.
Ingår i Molecular Cancer Research, s. 1243-1253, 2016.
DOI för Heparanase Promotes Glioma Progression and is Inversely Correlated with Patient Survival.
-
miR-196a Is Specifically Regulated in FDG-PET Positive and Negative Small Intestinal Neuroendocrine Tumor Patients at Late Stage of Disease
Ingår i Neuroendocrinology, s. 115-115, 2016.
-
Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors
Ingår i Immunotherapy, s. 1355-1361, 2016.
DOI för Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors
-
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
Ingår i EMBO Molecular Medicine, s. 702-711, 2016.
DOI för Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer Ladda ner fulltext (pdf) av Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
-
Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer
Ingår i BioDrugs, s. 75-89, 2015.
DOI för Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer Ladda ner fulltext (pdf) av Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer
-
Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival
Ingår i Cancer Research, s. 4504-4516, 2015.
-
Immunological shielding by induced recruitment of regulatory T lymphocytes delays rejection of islets transplanted to muscle
Ingår i Cell Transplantation, s. 263-276, 2015.
-
Immunological Shielding by Induced Recruitment of Regulatory T-Lymphocytes Delays Rejection of Islets Transplanted in Muscle
Ingår i Cell Transplantation, s. 263-276, 2015.
-
Mesenchymal stromal cells supportendothelial cell interactions in anintramuscular islet transplantation model
Ingår i Regenerative Medicine Research, 2015.
DOI för Mesenchymal stromal cells supportendothelial cell interactions in anintramuscular islet transplantation model Ladda ner fulltext (pdf) av Mesenchymal stromal cells supportendothelial cell interactions in anintramuscular islet transplantation model
-
Other Novel Therapies: Biomarkers, microRNAs and microRNA Inhibitors, DNA Methylation, Epigenetics, Immunotherapy and Virotherapy
Ingår i Neuroendocrine Tumors, s. 248-262, 2015.
-
A Hexon and Fiber-modified Adenovirus Expressing CD40L Improves the Antigen Presentation Capacity of Dendritic Cells
Ingår i Journal of immunotherapy (1997), s. 155-162, 2014.
-
Adenovirus Encoded Helicobacter pylori Neutrophil Activating Protein Promotes Maturation of DCs with Th-1 Polarization, Improved Antigen Presentation and Migration
Ingår i Molecular Therapy, s. S242-S243, 2014.
-
Allogeneic lymphocyte-licensed DCs expand T cells withimproved antitumor activity and resistance to oxidative stress andimmunosuppressive factors
Ingår i Molecular Therapy Methods & Clinical Development, 2014.
-
Allogeneic Lymphocyte-Licensed DCs Expand TCR/CAR-Engineered T Cells, Which Are Insensitive To Oxidative Stress and Immunosuppressive Factors
Ingår i Molecular Therapy, s. S62-S62, 2014.
-
Engineering Regulatory Cells With a T Cell Receptor for Controlled Activation
Ingår i Molecular Therapy, s. S180-S180, 2014.
-
Histidine-Rich Glycoprotein (HRG): A Novel Gene-Therapy Effector for the Treatment of Cancer
Ingår i Molecular Therapy, s. S243-S244, 2014.
-
Long-term episomal gene transfer for safe engineering of T-cells for adoptive cell therapy of cancer
Ingår i Human Gene Therapy, s. A50-A50, 2014.
-
Preclinical Safety Assessment of Ad[I/PPT-E1A], a Novel Oncolytic Adenovirus for Prostate Cancer
Ingår i Human Gene Therapy Clinical Development, s. 7-15, 2014.
-
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
Ingår i BMC Cancer, s. 30-, 2014.
DOI för Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice Ladda ner fulltext (pdf) av Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
-
Vector-Encoded Helicobacter pylori Neutrophil-Activating Protein Promotes Maturation of Dendritic Cells with Th1 Polarization and Improved Migration
Ingår i Journal of Immunology, s. 2287-2296, 2014.
-
Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
Ingår i PLOS ONE, s. e54952-, 2013.
DOI för Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures Ladda ner fulltext (pdf) av Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
-
An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors
Ingår i Molecular Therapy, s. 2008-2018, 2013.
DOI för An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors Ladda ner fulltext (pdf) av An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors
-
Genetically engineered T cells for the treatment of cancer
Ingår i Journal of Internal Medicine, s. 166-181, 2013.
DOI för Genetically engineered T cells for the treatment of cancer
-
Histidine-Rich Glycoprotein (HRG): A Novel Gene-Therapy Effector for the Treatment of Cancer
Ingår i Molecular Therapy, s. S241-S241, 2013.
-
Islet Engraftment and Revascularization in Clinical and Experimental Transplantation
Ingår i Cell Transplantation, s. 243-251, 2013.
DOI för Islet Engraftment and Revascularization in Clinical and Experimental Transplantation
-
Strategic recruitment of proangiogenic leukocytes to the ischemic hindlimb increases functional tissue perfusion
Ingår i European Journal of Clinical Investigation, s. 27-27, 2013.
-
Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
Ingår i Human Gene Therapy, s. 766-775, 2013.
DOI för Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy Ladda ner fulltext (pdf) av Tat‐PTD‐modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
-
Virotherapy of Neuroendocrine Tumors
Ingår i Neuroendocrinology, s. 26-34, 2013.
-
Age-related somatic structural changes in the nuclear genome of human blood cells
Ingår i American Journal of Human Genetics, s. 217-228, 2012.
DOI för Age-related somatic structural changes in the nuclear genome of human blood cells
-
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Ingår i Journal of Neuroinflammation, s. 112-, 2012.
DOI för CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery Ladda ner fulltext (pdf) av CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
-
T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells
Ingår i Proceedings of the National Academy of Sciences of the United States of America, s. 15877-15881, 2012.
-
Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
Ingår i Journal of Virology, s. 13114-13123, 2011.
DOI för Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors Ladda ner fulltext (pdf) av Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
-
Oncolytic Viruses for the Treatment of Neuroendocrine Tumors
Ingår i Hormone and Metabolic Research, s. 877-883, 2011.
DOI för Oncolytic Viruses for the Treatment of Neuroendocrine Tumors
-
Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
Ingår i Cancer Research, s. 1805-1815, 2011.
DOI för Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
-
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
Ingår i Gene Therapy, s. 752-762, 2010.
-
Clinical Adenoviral Gene Therapy for Prostate Cancer
Ingår i Human Gene Therapy, s. 807-813, 2010.
DOI för Clinical Adenoviral Gene Therapy for Prostate Cancer
-
Generation of antigen-specific cytolytic T cells for prostate cancer therapy
Ingår i Human Gene Therapy, s. 1422-1422, 2010.
-
High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals
Ingår i The Prostate, s. 70-81, 2009.
DOI för High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals Ladda ner fulltext (pdf) av High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals
-
Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue
Ingår i Acta Oncologica, s. 391-400, 2009.
DOI för Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue Ladda ner fulltext (pdf) av Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue
-
CD8(+) T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients
Ingår i Cancer Immunology and Immunotherapy, s. 399-409, 2008.
-
CpG oligonucleotides demonstrate increased therapeutic efficacy compared to BCG in an aggressive orthotopic bladder cancer model
Ingår i Journal of immunotherapy (1997), s. 34-42, 2008.
-
CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity
Ingår i Journal of immunotherapy (1997), s. 34-42, 2008.
-
Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region
Ingår i Cancer Gene Therapy, s. 203-213, 2008.
-
Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells
Ingår i British Journal of Haematology, s. 188-199, 2008.
DOI för Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells Ladda ner fulltext (pdf) av Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells
-
A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
Ingår i Clinical Cancer Research, s. 2455-2462, 2007.
DOI för A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
-
Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy
Ingår i The Prostate, s. 389-395, 2007.
DOI för Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy Ladda ner fulltext (pdf) av Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy
-
Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model
Ingår i Cancer Gene Therapy, s. 233-240, 2007.
-
Adenovirus-Mediated CD40 Ligand Therapy Induces Tumor Cell Apoptosis and Systemic Immunity in the TRAMP-C2 Mouse Prostate Cancer Model
Ingår i The Prostate, s. 831-838, 2006.